Source link : https://europeans.biz/germany-2/germanys-merck-eyes-life-science-deals-but-muted-2026-outlook-knocks-shares-reuters/
Germany’s Merck is actively pursuing growth opportunities through potential life science acquisitions as part of its strategic expansion efforts. However, the company’s subdued financial outlook for 2026 has dampened investor enthusiasm, leading to a decline in its share price. The pharmaceutical and chemicals giant’s cautious forecast highlights challenges ahead, even as it underscores its commitment […]
—-
Author : jeepeg
Publish date : 2025-10-19 12:52:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8
in News